Are you juggling work and family while running on empty
In this comprehensive guide, well explore how these medications work specifically during menopause, when you might expect to see results, and how they can be integrated with lifestyle changes and hormone optimization
The SURPASS-4 trial (ClinicalTrials.gov number, NCT03730662), which compared tirzepatide with insulin glargine, enrolled patients with increased cardiovascular risk, and the SURPASS-CVOT trial (NCT04255433) is ongoing to compare tirzepatide with dulaglutide and to provide a more comprehensive assessment of cardiovascular safety
Actionable Insights For those battling type 2 diabetes or obesity, semaglutide offers a potent solution
This information helps healthcare professionals assess whether there may be a connection to your medication or other contributing factors
Butler LM, Koh W-P, Lee H-P, Yu MC, London SJ: Dietary fiber and reduced cough with phlegm: a cohort study in Singapore